AMRN Q3 2018 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$55M+16.8% YoY

Gross Profit

$42M75.5% margin

Operating Income

-$22M-40.2% margin

Net Income

-$24M-44.2% margin

EPS (Diluted)

$-1.66

QoQ Revenue Growth

+5.1%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$210M

Total Liabilities

$263M

Stockholders' Equity

-$53M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$55M	$47M	+16.8%
Gross Profit	$42M	$35M	+17.9%
Operating Income	-$22M	-$8M	-163.3%
Net Income	-$24M	-$11M	-126.1%

Revenue Segments

Product

$55M99%

License

$350,0001%